PHARMACEUTICAL PRODUCTS IN THE ENVIRONMENT: SOURCES, EFFECTS AND RISKS

Pharmaceuticals and personal care products have become an environmental problem in recent years. Their physicochemical properties and persistence in the environment have allowed the distribution of degradates and parent compounds in water, soil, air and food. The widespread use of pharmaceuticals an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: John F. NARVAEZ, Claudio JIMÉNEZ
Formato: article
Lenguaje:EN
Publicado: Universidad de Antioquia 2012
Materias:
Acceso en línea:https://doaj.org/article/bae4cd54083447409e532d171494ddbf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bae4cd54083447409e532d171494ddbf
record_format dspace
spelling oai:doaj.org-article:bae4cd54083447409e532d171494ddbf2021-11-19T04:12:56ZPHARMACEUTICAL PRODUCTS IN THE ENVIRONMENT: SOURCES, EFFECTS AND RISKS0121-40042145-2660https://doaj.org/article/bae4cd54083447409e532d171494ddbf2012-04-01T00:00:00Zhttps://revistas.udea.edu.co/index.php/vitae/article/view/10865https://doaj.org/toc/0121-4004https://doaj.org/toc/2145-2660Pharmaceuticals and personal care products have become an environmental problem in recent years. Their physicochemical properties and persistence in the environment have allowed the distribution of degradates and parent compounds in water, soil, air and food. The widespread use of pharmaceuticals and personal care products in hospitals, domestic residences, agricultural and industrial facilities has increased their discharge into the water bodies, and its toxicity has started to manifest in different biological components of ecosystems. The development of methods for sample treatment and instrumental analysis techniques has enabled the separation, identification and quantification of active ingredients and degradates with higher environmental impact, at concentrations of parts per billion or even parts per trillion. In addition, in vitro and in vivo assays have demonstrated their ecotoxicity in water, driving them to the classification of emerging organic pollutants, whose waste is indeterminate. Although their adverse effects are still unknown, they could have strong implications for global public health. This review presents the dynamics and the development of research over the past ten years about the presence of non-steroidal anti-inflammatory analgesics, antihypertensives, antibiotics and other drugs in water bodies. Similarly, it described the impact of pharmaceutical activity, hospital services and domestic effluents on water quality. John F. NARVAEZClaudio JIMÉNEZUniversidad de AntioquiaarticleToxicity testsenvironmental pollutantsorganic pollutantsanalgesicspharmaceuticals and personal care products.Food processing and manufactureTP368-456Pharmaceutical industryHD9665-9675ENVitae, Vol 19, Iss 1 (2012)
institution DOAJ
collection DOAJ
language EN
topic Toxicity tests
environmental pollutants
organic pollutants
analgesics
pharmaceuticals and personal care products.
Food processing and manufacture
TP368-456
Pharmaceutical industry
HD9665-9675
spellingShingle Toxicity tests
environmental pollutants
organic pollutants
analgesics
pharmaceuticals and personal care products.
Food processing and manufacture
TP368-456
Pharmaceutical industry
HD9665-9675
John F. NARVAEZ
Claudio JIMÉNEZ
PHARMACEUTICAL PRODUCTS IN THE ENVIRONMENT: SOURCES, EFFECTS AND RISKS
description Pharmaceuticals and personal care products have become an environmental problem in recent years. Their physicochemical properties and persistence in the environment have allowed the distribution of degradates and parent compounds in water, soil, air and food. The widespread use of pharmaceuticals and personal care products in hospitals, domestic residences, agricultural and industrial facilities has increased their discharge into the water bodies, and its toxicity has started to manifest in different biological components of ecosystems. The development of methods for sample treatment and instrumental analysis techniques has enabled the separation, identification and quantification of active ingredients and degradates with higher environmental impact, at concentrations of parts per billion or even parts per trillion. In addition, in vitro and in vivo assays have demonstrated their ecotoxicity in water, driving them to the classification of emerging organic pollutants, whose waste is indeterminate. Although their adverse effects are still unknown, they could have strong implications for global public health. This review presents the dynamics and the development of research over the past ten years about the presence of non-steroidal anti-inflammatory analgesics, antihypertensives, antibiotics and other drugs in water bodies. Similarly, it described the impact of pharmaceutical activity, hospital services and domestic effluents on water quality.
format article
author John F. NARVAEZ
Claudio JIMÉNEZ
author_facet John F. NARVAEZ
Claudio JIMÉNEZ
author_sort John F. NARVAEZ
title PHARMACEUTICAL PRODUCTS IN THE ENVIRONMENT: SOURCES, EFFECTS AND RISKS
title_short PHARMACEUTICAL PRODUCTS IN THE ENVIRONMENT: SOURCES, EFFECTS AND RISKS
title_full PHARMACEUTICAL PRODUCTS IN THE ENVIRONMENT: SOURCES, EFFECTS AND RISKS
title_fullStr PHARMACEUTICAL PRODUCTS IN THE ENVIRONMENT: SOURCES, EFFECTS AND RISKS
title_full_unstemmed PHARMACEUTICAL PRODUCTS IN THE ENVIRONMENT: SOURCES, EFFECTS AND RISKS
title_sort pharmaceutical products in the environment: sources, effects and risks
publisher Universidad de Antioquia
publishDate 2012
url https://doaj.org/article/bae4cd54083447409e532d171494ddbf
work_keys_str_mv AT johnfnarvaez pharmaceuticalproductsintheenvironmentsourceseffectsandrisks
AT claudiojimenez pharmaceuticalproductsintheenvironmentsourceseffectsandrisks
_version_ 1718420516625186816